Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients’ point of view
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Gastroenterología y Hepatología
- Vol. 41 (7) , 423-431
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based studyDigestive and Liver Disease, 2016
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative ColitisGastroenterology, 2014
- Aféresis en enfermedad inflamatoria intestinal. ¿Una opción válida?Gastroenterología y Hepatología, 2012
- Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registryJournal of Gastroenterology, 2011
- Processed blood volume impacts clinical efficacy in patients with ulcerative colitis undergoing adsorptive depletion of myeloid lineage leucocytesJournal of Gastroenterology, 2011
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A ReviewAmerican Journal of Gastroenterology, 2009
- A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitisJournal of Gastroenterology, 2008
- Studies on the Mechanisms of Leukocyte Adhesion to Cellulose Acetate Beads: An In Vitro Model to Assess the Efficacy of Cellulose Acetate Carrier‐based Granulocyte and Monocyte Adsorptive ApheresisTherapeutic Apheresis and Dialysis, 2003
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980